Suppr超能文献

针对不同解剖部位和年龄的保守流感 B 病毒表位的 CD8 T 细胞应答。

CD8 T-cell responses towards conserved influenza B virus epitopes across anatomical sites and age.

机构信息

Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Parkville, VIC, Australia.

Infection and Immunity Program & Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.

出版信息

Nat Commun. 2024 Apr 29;15(1):3387. doi: 10.1038/s41467-024-47576-y.

Abstract

Influenza B viruses (IBVs) cause substantive morbidity and mortality, and yet immunity towards IBVs remains understudied. CD8 T-cells provide broadly cross-reactive immunity and alleviate disease severity by recognizing conserved epitopes. Despite the IBV burden, only 18 IBV-specific T-cell epitopes restricted by 5 HLAs have been identified currently. A broader array of conserved IBV T-cell epitopes is needed to develop effective cross-reactive T-cell based IBV vaccines. Here we identify 9 highly conserved IBV CD8 T-cell epitopes restricted to HLA-B07:02, HLA-B08:01 and HLA-B35:01. Memory IBV-specific tetramerCD8 T-cells are present within blood and tissues. Frequencies of IBV-specific CD8 T-cells decline with age, but maintain a central memory phenotype. HLA-B07:02 and HLA-B08:01-restricted NP epitope-specific T-cells have distinct T-cell receptor repertoires. We provide structural basis for the IBV HLA-B07:02-restricted NS1 (11-mer) and HLA-B*07:02-restricted NP epitope presentation. Our study increases the number of IBV CD8 T-cell epitopes, and defines IBV-specific CD8 T-cells at cellular and molecular levels, across tissues and age.

摘要

乙型流感病毒(IBV)会导致相当大的发病率和死亡率,但针对 IBV 的免疫仍然研究不足。CD8 T 细胞通过识别保守表位提供广泛的交叉反应性免疫,并减轻疾病严重程度。尽管 IBV 负担沉重,但目前仅鉴定出 18 种受 5 种 HLA 限制的 IBV 特异性 T 细胞表位。需要更广泛的保守的 IBV T 细胞表位来开发有效的基于交叉反应性 T 细胞的 IBV 疫苗。在这里,我们鉴定了 9 种高度保守的受 HLA-B07:02、HLA-B08:01 和 HLA-B35:01 限制的 IBV CD8 T 细胞表位。记忆性 IBV 特异性四聚体 CD8 T 细胞存在于血液和组织中。IBV 特异性 CD8 T 细胞的频率随年龄增长而下降,但仍保持中央记忆表型。HLA-B07:02 和 HLA-B08:01 限制的 NP 表位特异性 T 细胞具有独特的 T 细胞受体库。我们为 IBV HLA-B07:02 限制的 NS1(11 聚体)和 HLA-B*07:02 限制的 NP 表位呈递提供了结构基础。我们的研究增加了 IBV CD8 T 细胞表位的数量,并在细胞和分子水平上定义了跨组织和年龄的 IBV 特异性 CD8 T 细胞。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b29/11059233/06664f386e8d/41467_2024_47576_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验